QGEN - QIAGEN N.V.
46.88
-0.770 -1.642%
Share volume: 1,975,041
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$47.65
-0.77
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | |
| Report Date | 05-01-2024 | 08-02-2024 | |
| Cash flow financing | -292.088 M | -127.382 M | |
| Other financing cash flows | 0.000 | 0.000 | |
| Cash flow | 133.078 M | 166.617 M | |
| Net income | 80.673 M | -183.460 M | |
| Depreciation | 54.330 M | 53.393 M | |
| Changes in inventories | 401.745 M | 321.750 M | |
| Changes in receivables | 343.892 M | 355.300 M | |
| Investing Cashflow | 6.431 M | -17.837 M | |
| Net Borrowings | 358.212 M | 248.890 M | |
| Investing Activity Other | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | |
| Capital Expenditures | -38.360 M | -38.910 M | |
| Cash Change | 893.133 M | 890.240 M |